Author: Boldt Joachim Kumle Bernhard Suttner Stefan
Publisher: Informa Healthcare
ISSN: 1465-6566
Source: Expert Opinion on Pharmacotherapy, Vol.3, Iss.9, 2002-09, pp. : 1267-1272
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Cost Considerations in the Use of Anaesthetic Drugs
By Smith I.
PharmacoEconomics, Vol. 19, Iss. 5, 2001-01 ,pp. :
Pharmacoeconomic considerations with statin therapy
By Speidel Katie M Hilleman Daniel E
Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 10, 2006-07 ,pp. :
Pharmacoeconomic Considerations in Treating Actinic Keratosis
PharmacoEconomics, Vol. 27, Iss. 6, 2009-06 ,pp. :
Pharmacoeconomic Considerations in Treating Ovarian Cancer
By Bodurka-Bevers D. Sun C.C. Gershenson D.M.
PharmacoEconomics, Vol. 17, Iss. 2, 2000-02 ,pp. :